retatrutide amino (LY3437943) | GCGR/GLP-1R/GIPR Agonist | CAS 2381089-83-2 Retatrutide

F., Li, Z., Ping, P., Dai, J

While these medications don't directly damage eye structures, clinical evidence shows they may worsen diabetic retinopathy in specific circumstancesparticularly when patients with pre-existing retinal disease experience rapid blood sugar improvements

Responsible distribution for the research community Limitless Life creates products that intended strictly for research purposes

Published on February 19th, 2025

Pros: Long track record of safety

Prescribed through a pharmaceutical-grade compounding pharmacy, taken once daily, it keeps the tissue environment primed for repair around the clock